161 Aufrufe 161 0 Kommentare 0 Kommentare

    Neurovascular Devices Market worth $7.22 billion in 2030 with 9.3% CAGR | MarketsandMarkets

    DELRAY BEACH, Fla., Nov. 6, 2025 /PRNewswire/ -- The global Neurovascular Devices Market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$7.22 billion by the end of the period. Several factors influence the neurovascular devices market. The two most significant ones are the rising incidence of neurovascular diseases and the expansion of healthcare infrastructure across emerging economies, which are key drivers for the neurovascular devices market. The increasing prevalence of conditions such as stroke, cerebral aneurysms, and arteriovenous malformations is largely due to aging populations, sedentary lifestyles, poor dietary habits, rising rates of hypertension and diabetes, and increased exposure to risk factors like smoking and alcohol consumption. As these diseases often require urgent and specialized interventions, the demand for advanced neurovascular devices such as thrombectomy systems, embolization coils, and flow diverters continues to grow.

    MarketsandMarkets Logo

    Certain challenges may, however, impede market expansion. The high procedural costs of neurovascular surgeries and related products pose a major barrier, as many patients—especially in low- and middle-income regions—cannot afford advanced technologies. Additionally, stringent regulatory approval processes for medical devices further slowdown the market penetration.

    Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847

    Browse in-depth TOC on "Neurovascular Devices Market"

    150 - Tables
    70 - Figures
    300 - Pages

    By disease pathology, the global neurovascular devices market is divided into five main segments: cerebral aneurysms, ischemic strokes, carotid artery stenosis, arteriovenous malformations and fistulas, and other disease pathologies.

    The high incidence of cerebral aneurysms results from a combination of genetic, physiological, and lifestyle factors. People with a family history or certain genetic disorders are more vulnerable, while chronic hypertension, smoking, and atherosclerosis further weaken blood vessel walls. Age and gender also influence risk, with middle-aged adults and women being more susceptible. Additionally, lifestyle choices like alcohol abuse and sedentary behaviors add to vascular stress, collectively increasing the likelihood of aneurysm formation.

    Seite 1 von 4 





    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Neurovascular Devices Market worth $7.22 billion in 2030 with 9.3% CAGR | MarketsandMarkets DELRAY BEACH, Fla., Nov. 6, 2025 /PRNewswire/ - The global Neurovascular Devices Market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a …

    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2025 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero